ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO859

MoVE TRIAL Protocol: MotiVational Strategies to Empower African American Patients to Improve Dialysis Adherence

Session Information

Category: Diversity and Equity in Kidney Health

  • 900 Diversity and Equity in Kidney Health

Authors

  • Medepalli, Anita, Mercer University, Macon, Georgia, United States
  • Wallace, Marylou, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • St. Julien, Zuri Naeem, University of Missouri-St Louis, St Louis, Missouri, United States
  • Forbess, Julianna, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Prigmore, Heather Leanne, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Greevy, Robert, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Schrauben, Sarah J., University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Nair, Devika, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Fissell, Rachel B., Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Lewis, Julia, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Cavanaugh, Kerri L., Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Resnicow, Kenneth A., University of Michigan, Ann Arbor, Michigan, United States
  • Wolever, Ruth Q., Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Umeukeje, Ebele M., Vanderbilt University Medical Center, Nashville, Tennessee, United States
Background

Compared to Whites, African Americans (AA) have a four-fold higher prevalence of end-stage kidney disease (ESKD) and higher hemodialysis (HD) treatment non-adherence rates. We pilot-tested (NCT05003115) and confirmed feasibility of culturally tailored motivational interviewing (MI) to improve HD adherence in AA. We describe our efficacy trial protocol (NCT05735743) and hypothesize that the intervention improves HD adherence.

Methods

Multi-site, 2-arm, parallel group (MI vs. Usual Care) RCT of ≥ 18 years old, AA HD patients (n=150, 2:4:2 stratified block randomization), who missed or shortened ≥1 session by ≥15 minutes/2 months before enrollment. Trained health coaches (HC) conduct MI sessions. Intervention fidelity is assessed pre-enrollment and mid-RCT, via MI Treatment Integrity Scale. MI patients receive 6 sessions in 8 weeks, culturally tailored to prioritize AA patient-identified contributors to nonadherence, including racial identity (Fig 1). Survey completion and EMR abstraction occur at baseline, 8, and 24 weeks; adherence data is abstracted to week 24. Primary and secondary outcomes are proportions of missed HD minutes at 8 and 24 weeks, respectively.

Results

IRB approval was obtained. Manual of procedures, intervention manual, and study charter were developed. HC received protocol, logistics, and further MI training. Enrollment was launched upon DSMB and site approval. RCT activities are ongoing.

Conclusion

Findings will determine efficacy of culturally tailored MI on improving HD adherence in AA. Improved HD adherence will reduce morbidity, mortality, healthcare costs, and racial disparities in ESKD.

Figure 1

Funding

  • NIDDK Support